Search Login Register

SB 209670 Summary

Description: an ET(A) and ET(B) endothelin receptor antagonist; structure in first source

Also Known As: 3-(2-(carboxymethoxy)-4-methoxyphenyl)-1-(3,4-(methylenedioxy)phenyl)-5-(prop-1-yloxy)indan-2-carboxylic acid; SB-209670

Networked: 25 relevant articles (3 outcomes, 4 trials/studies) for this Bio-Agent

Key Diseases for which SB 209670 is Relevant

  1. Stroke (Strokes) : 1 outcome 1 study in 3 results
  2. Neointima : 1 outcome in 3 results
  3. Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) : 1 outcome in 2 results
  4. Ventricular Premature Complexes (Premature Ventricular Contraction) : 1 outcome in 1 result
  5. Ischemia : 1 study in 3 results
Show All >>

Drugs Related to SB 209670

  1. Endothelin Receptors (Endothelin Receptor)
  2. cyclo(Trp-Asp-Pro-Val-Leu)
  3. Bradykinin B2 Receptor
  4. Captopril (Capoten)
  5. Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
  6. PD 142893
  7. icatibant
  8. ramiprilat
  9. Endothelins (Endothelin)
  10. SB 234551
Show All >>

Therapies Related to SB 209670

  1. Angioplasty (Angioplasty, Transluminal)
  2. Intra-Arterial Infusions
  3. Balloon Angioplasty

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.